Emergent Announces Additions to Leadership Team

03.14.2022

Emergent is pleased to announce the addition of two senior leaders to its CDMO and Quality & Compliance organizations.

Bill Hartzel is joining Emergent as Senior Vice President for CDMO effective March 14. Hartzel will lead Emergent’s CDMO business, reporting to Chief Operating Officer Adam Havey. Hartzel most recently served as Chief Commercial Officer for Woodstock Sterile Solutions.

Effective April 1, Coleen Glessner will join Emergent as Executive Vice President with enterprise responsibility for the Global Quality and Ethics and Compliance functions reporting directly to the CEO, Robert Kramer. Glessner joins the company from Alexion Pharmaceuticals where she served as Senior Vice President and Chief Quality Officer.

Read the full announcement here.

Emergent CDMO

In The News

06.02.2020

Emergent Continues to Expand Role in Support of Development and Manufacturing of COVID-19 Vaccines

Emergent BioSolutions recently announced that it has been issued a task order under an existing contract with the Biomedical...

06.01.2020

Emergent BioSolutions Joins U.S. Government’s Warp Speed Program in Landmark Public-Private CDMO Partnership for COVID-19 Vaccine Development and Manufacturing

Emergent and HHS expand 2012 CIADM public-private partnership with task order valued at approximately $628 million for rapid...

03.19.2020

Vaxart AGREEMENT for Experimental Oral Vaccine Candidate for Coronavirus Disease

GAITHERSBURG, Md.,March 18, 2020(GLOBE NEWSWIRE) --Emergent BioSolutions Inc.(NYSE:EBS) announced today that it has entered...